Ideas

September 20, 2017

Published by admin_auro at September 20, 2017

Categories

Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients: A pharmaceutical mixture encompassing Beta-Cryptoxanthin and Mangiferin (BCM) increases the expression of ERBB2/Her2 and promotes dedifferentiation of cardiomyocytes via down regulation of its target gene, 21/September/2017, 1.51 am

Introduction: What they say A recent study from the Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel shows that “ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.” This study was […]

September 20, 2017

Published by admin_auro at September 20, 2017

Categories

Cancer
Ideas

Natural product-derived therapy for gynecologic cancers: A therapeutic mix encompassing Withaferin A, Astaxanthin, 5-aza-2′-deoxycytidine, Cirivastatin, PEITC, Tubastatin, & Celastrol (WAAACPTC) inhibits the expression of HDAC6, acetylates tumor suppressor proteins, activates tumor suppressor function, and stifles the progression of ARID1A-mutated ovarian cancers via up-regulation of its target gene, 21/September/2017, 1.50 am

Introduction: What they say: A study from Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA shows that “ARID1A-mutated ovarian cancers depend on […]

September 19, 2017

Published by admin_auro at September 19, 2017

Categories

Natural product-based Anti-ageing and Life extension therapy: A pharmaceutical mixture encompassing Fisetin, Epigallocatechin-3-gallate, Lupeol, & Catalpol (FELC) increases CHIP levels, increases monoubiquitylation of insulin receptor (INSR), decreases INSR protein levels and enhances lifespan via down regulation of its target gene, 19/September/2017, 11.25 pm

Introduction: What they say A study from Institute for Cell Biology, University of Bonn, Ulrich-Haberland Str. Bonn, Germany; and Institute for Genetics and CECAD Research Center, […]

September 19, 2017

Published by admin_auro at September 19, 2017

Categories

Molecular therapy for Cardiomyopathy: Edaravone (brand names: Radicava and Radicut), an anti-stroke drug, decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy via up regulation of its target gene, 19/September/2017, 11.24 pm

Introduction: What they say A recent study from the Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; and Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA shows that “Trbp regulates heart […]